Latest Posts

Posted on January 12, 2012 by |
A Bill in the House of Representatives (HR 3699) sponsored by Rep. Darrell Issa, the Research Works Act, seeks to block federal policy requiring free access to federally funded biomedical research results. While this Bill has gotten some attention as…
Read more »

Posted on January 12, 2012 by |
The National Science Board, NSF’s oversight body, will maintain the two Merit Review Criteria – Intellectual Merit and Broader Impact – according to a new report recently published. The Board determined that both criteria were important and appropriate. They have…
Read more »

Posted on January 12, 2012 by |
The Advisory Committee to the Director of NIH has issued a Request for Information to collect information from the community that can be used to develop recommendations regarding the “management, integration, and analysis of research data and administrative data.  Comments…
Read more »

Posted on January 11, 2012 by |
A new blog called FDA Voice has been created to provide insights into the mission and ongoing work of FDA. The content will address various topics of interest to agency stakeholders. Information about all of FDA’s interactive media offerings, including…
Read more »

Posted on January 9, 2012 by |
NIH has announced the establishment of a new center, the National Center for Advancing Translational Sciences (NCATS), which will focus on supporting identifying and overcoming barriers that slow the development of effective medical treatments and cures. At the same time, the National Center for Research…
Read more »

Posted on January 9, 2012 by | 0 Comments
Bloomberg is reporting that FDA granted 30 new drug approvals in 2011, the highest number in a single year since 2004. The increase is attributed to pharmaceutical manufacturers working more closely with FDA to better understand the agency’s requirements, and…
Read more »

Posted on January 9, 2012 by |
Last month, NIH announced some changes to its AREA (Academic Research Enhancement Award) Program, which is focused on funding small scale research projects at institutions with less intensive research programs. This is specifically targeted at investigators working in institutions with…
Read more »

Posted on January 8, 2012 by |
The year just ended was a busy one for the US Food and Drug Administration (FDA), particularly with regard to inspections and enforcement activities. The FDAZilla blog predicted on November 30, 2011, that the number of 483 Forms issued for…
Read more »